BuybackOct 20, 2026, 04:41 PM
Lakefront Biotherapeutics Completes Share Repurchase Program
AI Summary
Lakefront Biotherapeutics NV announced the completion of its share repurchase program. Between October 12 and October 16, 2026, the company bought back 107,804 of its own shares for a total of €2,854,365.69. The average price paid was €26.48 per share. This marks the full completion of the repurchase program that was initially announced on June 9, 2026. As of October 16, 2026, the company holds 1,985,157 of its own ordinary shares.
Key Highlights
- Lakefront Biotherapeutics repurchased 107,804 shares between October 12-16, 2026.
- Total cost of share repurchases was €2,854,365.69.
- Average price paid per share was €26.48.
- Lowest price paid was €26.04 and highest was €26.98.
- As of October 16, 2026, Lakefront holds 1,985,157 own ordinary shares.
- The repurchase program announced on June 9, 2026, has been fully completed.
Price Impact
More from GLPG